CLDX
Celldex TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CLDX Profile
Celldex Therapeutics, Inc.
A clinical stage biotechnology company that developing vaccines for cancer and infectious and inflammatory diseases
Perryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827
--
Celldex Therapeutics, Inc., is incorporated in Delaware. The Company is a biopharmaceutical company dedicated to exploring the science of mast cell biology and developing therapeutic antibodies that have the ability to engage the human immune system and directly affect key pathways to improve the lives of patients with severe inflammation, allergies, autoimmune and other devastating diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell-mediated diseases for which existing treatments are inadequate.
